Ucb Pharma S.A.
Records under this name other than the patents Ucb Pharma S.A. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 52 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,486,662 | DNA encoding antibody molecules having specificity for human IL-6 Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,096,668 | Methods for making antibody molecules having specificity for human IL-6 Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,631,015 | Methods for treating IL-6 mediated diseases with antibody molecules specific for IL-6 Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US D676,552 | Needle cap for a medication administration device Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 7,888,344 | Fused thiazole derivatives as kinase inhibitors Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 7,910,618 | Albumin-Binding Conjugates Comprising a Fatty Acid and Peg Formerly held In force · High confidence | In force | High confidence | |
| US 7,989,594 | Modified Antibody Fab Fragments Formerly held In force · High confidence | In force | High confidence | |
| US 8,633,194 | Pharmaceutical composition of piperazine derivatives Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,617,847 | Nucleic acids encoding antibody molecules which bind IL-17A and IL-17F Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,890,219 | Methods of treating an IL-17A mediated pathological condition Formerly held In force · From the USPTO record | In force | From the USPTO record |